A curative combination cancer therapy achieves high fractional cell killing through low cross-resistance and drug additivity.
Saved in:
| Title: | A curative combination cancer therapy achieves high fractional cell killing through low cross-resistance and drug additivity. |
|---|---|
| Authors: | Palmer AC; Laboratory of Systems Pharmacology, Harvard Medical School, Boston, United States., Chidley C; Laboratory of Systems Pharmacology, Harvard Medical School, Boston, United States., Sorger PK; Laboratory of Systems Pharmacology, Harvard Medical School, Boston, United States.; Department of Systems Biology, Harvard Medical School, Boston, United States. |
| Source: | ELife [Elife] 2019 Nov 19; Vol. 8. Date of Electronic Publication: 2019 Nov 19. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: eLife Sciences Publications, Ltd Country of Publication: England NLM ID: 101579614 Publication Model: Electronic Cited Medium: Internet ISSN: 2050-084X (Electronic) Linking ISSN: 2050084X NLM ISO Abbreviation: Elife Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 31742555 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: A curative combination cancer therapy achieves high fractional cell killing through low cross-resistance and drug additivity. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Palmer+AC%22">Palmer AC</searchLink>; Laboratory of Systems Pharmacology, Harvard Medical School, Boston, United States.<br /><searchLink fieldCode="AU" term="%22Chidley+C%22">Chidley C</searchLink>; Laboratory of Systems Pharmacology, Harvard Medical School, Boston, United States.<br /><searchLink fieldCode="AU" term="%22Sorger+PK%22">Sorger PK</searchLink>; Laboratory of Systems Pharmacology, Harvard Medical School, Boston, United States.; Department of Systems Biology, Harvard Medical School, Boston, United States. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101579614%22">ELife</searchLink> [Elife] 2019 Nov 19; Vol. 8. <i>Date of Electronic Publication: </i>2019 Nov 19. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22eLife+Sciences+Publications%2C+Ltd%22">eLife Sciences Publications, Ltd </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101579614 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2050-084X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222050084X%22">2050084X </searchLink><i>NLM ISO Abbreviation: </i>Elife <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=31742555 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.7554/eLife.50036 Languages: – Code: eng Text: English Titles: – TitleFull: A curative combination cancer therapy achieves high fractional cell killing through low cross-resistance and drug additivity. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Palmer AC – PersonEntity: Name: NameFull: Chidley C – PersonEntity: Name: NameFull: Sorger PK IsPartOfRelationships: – BibEntity: Dates: – D: 19 M: 11 Text: 2019 Nov 19 Type: published Y: 2019 Identifiers: – Type: issn-electronic Value: 2050-084X Numbering: – Type: volume Value: 8 Titles: – TitleFull: ELife Type: main |
| ResultId | 1 |
